Twinbeech Capital »

Capricor Therapeutics shares owned by Twinbeech Capital

Quarter-by-quarter ownership of Capricor Therapeutics (CAPR) shares owned by Twinbeech Capital from 13F filings

Historical chart of Twinbeech Capital investment in Capricor Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Capricor Therapeutics held by Twinbeech Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Capricor Therapeutics by Twinbeech Capital

Quarter filed Position value Share count Share price at filing
2026-06-30 $682k 28k 24.08

More positions owned by Twinbeech Capital

Cme (CME)
Hilton Worldwide Holdings (HLT)
Boston Scientific Corporation (BSX)
Intercontinental Exchange (ICE)
Rollins (ROL)
Blackrock (BLK)
Howmet Aerospace (HWM)
Ss&c Technologies Holding (SSNC)
ON Semiconductor (ON)
WESCO International (WCC)
Five Below (FIVE)
Hewlett Packard Enterprise (HPE)
Burlington Stores (BURL)
McKesson Corporation (MCK)
Lauder Estee Cos Cl A (EL)

View all positions for Twinbeech Capital

Top funds holding Capricor Therapeutics

BlackRock
Tang Capital Management
Suvretta Capital Management
Vanguard Capital Management
State Street Corporation
Susquehanna International
Goldman Sachs Group
Citadel Advisors
RA Capital Management
Perceptive Advisors
Boxer Capital Management
Geode Capital Management
FMR
Ikarian Capital
Diadema Partners

View all funds holding Capricor Therapeutics